Background: Post-cardiotomy acute right ventricular failure (aRVF) constitutes a complex clinical challenge that might necessitate escalating interventions, including extracorporeal life support (ECLS). This study evaluates outcomes of adults requiring ECLS for post-cardiotomy acute right ventricular failure (aRVF) compared to other post-cardiotomy indications. Methods: In this multicenter, international, retrospective study, we analyzed patients undergoing post-cardiotomy ECLS from January 2000 to December 2020 and compared patients' characteristics and in-hospital mortality between aRVF and other indications groups. Results: Of 2010 patients, 240 (12%) had aRVF and 1770 (88%) had other indication for ECLS. Demographics were similar between groups (median age: 65 years [55-72]; p=0.217; males 60%; p=0.675). The aRVF group showed higher pre-operative right-sided cardiac dysfunction, including pre-existing right ventricular failure (aRVF: 22%; other indications: 8%; p<0.001) and biventricular failure (aRVF: 12%; other indications: 7%; p=0.013). aRVF patients more frequently underwent tricuspid valve surgery (aRVF: 20%; other indications: 13%; p=0.003) and aortic root procedures (aRVF: 24%; other indications: 13%). They also required longer ECLS support (aRVF: 135 hours [70-221]; other indications:116 hours [58-192]; p=0.025) and longer intensive care unit stay (aRVF: 15 days [7-291]; other indications: 13 days [6-25]; p=0.042). Despite more complications, including non-surgical bleeding (aRVF: 31%; other indications: 25%; p=0.042) and persistent right heart failure (aRVF: 50%; other indications: 17%; p<0.001), both in-hospital survival (aRVF: 59%; other indications: 61%; p=0.526) and long-term survival were comparable (log-rank p=0.17). Conclusions: Patients requiring ECLS for post-cardiotomy aRVF, despite higher pre-operative risks and complex clinical courses, achieve survival rates comparable to other indications patients.

Extracorporeal Life Support for Post-Cardiotomy Acute Right Ventricular Failure: a Retrospective Observational Multicenter Study

Loforte A;
2026-01-01

Abstract

Background: Post-cardiotomy acute right ventricular failure (aRVF) constitutes a complex clinical challenge that might necessitate escalating interventions, including extracorporeal life support (ECLS). This study evaluates outcomes of adults requiring ECLS for post-cardiotomy acute right ventricular failure (aRVF) compared to other post-cardiotomy indications. Methods: In this multicenter, international, retrospective study, we analyzed patients undergoing post-cardiotomy ECLS from January 2000 to December 2020 and compared patients' characteristics and in-hospital mortality between aRVF and other indications groups. Results: Of 2010 patients, 240 (12%) had aRVF and 1770 (88%) had other indication for ECLS. Demographics were similar between groups (median age: 65 years [55-72]; p=0.217; males 60%; p=0.675). The aRVF group showed higher pre-operative right-sided cardiac dysfunction, including pre-existing right ventricular failure (aRVF: 22%; other indications: 8%; p<0.001) and biventricular failure (aRVF: 12%; other indications: 7%; p=0.013). aRVF patients more frequently underwent tricuspid valve surgery (aRVF: 20%; other indications: 13%; p=0.003) and aortic root procedures (aRVF: 24%; other indications: 13%). They also required longer ECLS support (aRVF: 135 hours [70-221]; other indications:116 hours [58-192]; p=0.025) and longer intensive care unit stay (aRVF: 15 days [7-291]; other indications: 13 days [6-25]; p=0.042). Despite more complications, including non-surgical bleeding (aRVF: 31%; other indications: 25%; p=0.042) and persistent right heart failure (aRVF: 50%; other indications: 17%; p<0.001), both in-hospital survival (aRVF: 59%; other indications: 61%; p=0.526) and long-term survival were comparable (log-rank p=0.17). Conclusions: Patients requiring ECLS for post-cardiotomy aRVF, despite higher pre-operative risks and complex clinical courses, achieve survival rates comparable to other indications patients.
2026
2026 Mar 13:S0003-4975(26)00210-9
1
36
https://pubmed.ncbi.nlm.nih.gov/41833792/
Bianchi G, Perazzo A, Mariani S, van Bussel BCT, Di Mauro M, Wiedeman D, Saeed D, Pozzi M, Botta L, Boeken U, Samalavicius R, Bounader K, Hou X, Bunge...espandi
File in questo prodotto:
File Dimensione Formato  
ECMO RVF PELS.pdf

Accesso aperto

Descrizione: ECMO RVF PELS
Tipo di file: PDF EDITORIALE
Dimensione 4.27 MB
Formato Adobe PDF
4.27 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/2130551
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact